Business Context and Reporting Period
Company: MDxHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: March 2022 (Filing Date: March 3, 2022)
Context: This filing furnishes a press release dated March 2, 2022, and financial results as of December 31, 2021. The document explicitly states that the attached exhibits are furnished and not "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The provided text serves as a cover sheet and does not contain specific financial data points. The actual financial results for the period ended December 31, 2021, are located in the attached Exhibit 99.2, which is not included in the input text. Consequently, the following metrics are not available in this document:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt and Liquidity
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only references the existence of 2021 financial results in an attachment.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed in the provided text. These elements, if present, are contained within the attached press release (Exhibit 99.1) and financial results (Exhibit 99.2).
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release) for management commentary and strategic updates.
- Examine the attached Exhibit 99.2 (2021 Financial Results) for specific revenue, profit, and cash flow figures.
- Verify the status of the company's Form 20-F filing requirements as indicated in the form.
- Note that the information in the exhibits is not deemed "filed" under Section 18 of the Exchange Act.